Rifampin (2) , formerly known as rifampicin also, is a semisynthetic antibiotic derived from rifamycin B, a fermentation product of Streptomyces mediterranei (16) . It is an orally active, broad-spectrum antibiotic exhibiting no cross-resistance with other antibiotics in current clinical use. In vitro experiments have shown that this antibiotic is a specific inhibitor of bacterial deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase (EC 2.7.7.6), blocking the initiation of RNA chain synthesis but not affecting chain elongation (8, 11) . Rifampinresistant mutants of Escherichia coli (5, 18) , Staphylococcus aureus (20) , and Bacillus subtilis (4, 17) have all been shown to contain altered polymerases that are more resistant to the antibiotic in vitro. Recently, Zillig (13) reported that a modified , subunit of this enzyme is responsible for resistance to rifampin in an E. coli mutant.
Although the most important clinical application of rifampin is in the treatment of tuberculosis (1), little information is available regarding its mechanism of action on Mycobacterium tuberculosis. Recently, rifampin has shown promise against leprosy (14) , another mycobacterial disease. In the present report, we present the results of our research into the mechanism of rifampin action on mycobacteria, with M. smegmatis used as a model.
MATERIALS AND METHODS
Radiocbemicals. Uracil-2-'4C (52.5 mCi/mM), phenylalanine-1-'4C (52 mCi/mM), and adenosine triphos- (6) with bovine serum albumin used as a standard. Assay of RNA polymerase. Enzyme was assayed by using the procedure described by Burgess (3) . When the sensitivity of RNA polymerase to rifamycins was tested, antibiotic and enzyme were preincubated together for 3 min at 37 C, and the reaction was started by adding a solution containing nucleoside triphosphates and DNA.
Assay of RNA and protein synthesis in whole cells. RNA synthesis in whole cells was followed by measuring the incorporation of uracil-2-"4C (2.5 Ag/ml, 0.15 MtCi/ml) into the cold 5% trichloroacetic acid-insoluble fraction. Protein synthesis by whole cells was determined by measuring incorporation of phenylalanine-l-14C (1 tig/ml, 0.15 ACi/ml) into the cold 5% trichloroacetic acid-insoluble fraction. All incorporation experiments were performed with growing cultures in minimal medium adjusted to an absorbance of 0.07 at 650 nm immediately before addition of isotope.
Assay of radioactivity. Labeled RNA and protein samples were collected on glass fiber filters (Whatman GF/C) and washed with 10 ml of 2% trichloroacetic acid and then 10 ml of 95% ethanol. Washed filters were dried and counted in a liquid scintillation analyzer (Philips) using a scintillation solution containing 2.5 g of Premix M (Packard Instrument Co.) per liter of toluene.
RESULTS
Bactericidal effect of rifampin. Addition of antibiotic at 100 jg/ml to a growing culture of M.
smegmatis caused a rapid bacteriostasis followed by a much slower decrease in the viable count (Fig. 1 ). Higher concentrations of rifampin resulted in an increased bactericidal effect. Thus 800 ,ug/ml gave six times fewer survivors than 100 gg/ml after 48 hr of contact with the antibiotic.
Inhibition of uacil-2-14C and phenylalanine-l-14C incorporation in whole cells. Incorporation of uracil-2-14C into the acid-precipitable fraction by a growing culture of M. smegmatis was blocked by the addition of 200 gg/ml rifampin. Inhibition was complete after 1.5 to 2 min of contact with antibiotic (Fig. 2) . Under the same conditions, incorporation of phenylalanine-1-14C into the acid-precipitable fraction continued at a decreasing rate for about 6 min after the addition of rifampin (Fig. 3) .
Resumption of incorporation after removal of antibiotic. Preliminary experiments indicated that, when inhibited cultures were harvested and suspended in fresh rifampin-free medium, there was a partial recovery of uracil-2-14C and, subsequently, phenylalanine-1-14C incorporation. This recovery suggested that the slowness of killing (Fig. 1) might be caused by reversibility of the binding of rifampin to RNA polymerase; some caution must be exercised when comparing the recovery of incorporation and killing experiments, as they were performed in different media (minimal and TB, respectively). To exclude the possibility that resumption of uracil incorporation was simply dependent on the de novo synthesis of polymerase, an experiment was carried out in which protein synthesis after the removal of rifampin was inhibited by the addition of chloramphenicol (Fig. 4) . Chloramphenicol did not prevent the resumption of uracil-2-14C incorporation; the control culture containing rifampin and chloramphenicol showed no recovery. A parallel culture containing phenylalanine-)-'4C and chloramphenicol gave no resumption of incorporation.
Effect of rifampin on DNA-dependent RNA polymerase. Partially purified RNA polymerase from M. smegmatis was 90% inhibited by 1.0 ,ug/ml rifampin, whereas enzyme from a resistant mutant was not affected by this concentration of antibiotic (Fig. 5) plete by 3 min, whereas protein synthesis is not affected at all until 3 to 3.5 min. Further support 3- for the effect of rifampin on transcription comes from the data on RNA polymerase in a resistant mutant, because the mutant contains an altered / enzyme that has a markedly decreased sensitivity to the antibiotic in vitro. The fact that a mixture of sensitive and resistant RNA enzymes gave a 2-plateau of rifampin-resistant RNA polymerase OE /0 activity at about 50% (Fig. 5) 
